Clinical Trial

Comparison of the in Vivo Stability of 2 Cementless TKA Designs

Study acronym: ClessTKA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this randomized controlled trial is to analyze the stability of a cementless Total Knee Arthroplasty (TKA) over time and compare it to a well-documented implant in patients with knee osteoarthritis. The main aim is to answer if there is a difference in stability over time as a measure of long time survivorship in these 2 implants. 50 participants will be randomly allocated to receive either the Triathlon Tritanium (Stryker) or the Global Medacta Knee Sphere (GMK Sphere, Medacta) 3D printed cementless TKAs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-06; most recent amendment 2024-08-26.
Status change: Recruiting → Active, Not Recruiting 2024-08-26
Trial Details
NCT Number NCT05651009
Lead Sponsor Helse Møre og Romsdal HF
Collaborators: Oslo University Hospital, Medacta International SA
Conditions Knee Osteoarthritis
Enrollment 50 participants
Start Date 2022-12-06
Primary Completion 2028-06-25 (estimated)
Study Completion 2033-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-27